Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Viloxazine and the depressed schizophrenic--methodological issues

A A Kurland, A Nagaraju

Journal of Clinical Pharmacology

|January 1, 1981

Summary

This pilot study investigated viloxazine combined with antipsychotics for schizophrenia with depressive symptoms. No significant differences were found between viloxazine and placebo groups, suggesting further research on dosage is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

COVID-19 Associated Mucormycosis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2023

Same author

The psychopathology and measurement of environmental stress.

Community mental health journal·2013

Same author

Electroencephalogram of cats subjected to repeated minimal convulsive doses of electricity.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010

Same author

Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives.

Journal of medicinal chemistry·2002

Same author

LSD in the supportive care of the terminally ill cancer patient.

Journal of psychoactive drugs·1985

Same author

The prolactin response to flutroline hydrochloride in schizophrenic patients.

Journal of clinical pharmacology·1983

Area of Science:

Psychiatry and Pharmacology

Background:

Schizophrenia often presents with depressive symptoms, impacting patient outcomes.
Combination therapies are explored to manage complex symptom profiles in schizophrenia.

Purpose of the Study:

To evaluate the efficacy of viloxazine as an adjunct to antipsychotic treatment (chlorpromazine or haloperidol) in schizophrenic patients with depressive symptoms.
To assess the safety and tolerability of this combination therapy.

Main Methods:

A double-blind, placebo-controlled pilot study was conducted.
Patients received either viloxazine or a placebo, combined with either chlorpromazine or haloperidol.
Patient responses and side effects were monitored.

Main Results:

No statistically significant difference in efficacy was observed between the viloxazine and placebo groups.
The absence of apparent side effects raised questions about the adequacy of the viloxazine dosage used.
The combination therapy's clinical merit requires further investigation.

Conclusions:

The current pilot study did not demonstrate a clear benefit of adding viloxazine to standard antipsychotic treatment for depressive symptoms in schizophrenia.
Further research is warranted to determine optimal dosing and confirm the clinical utility of viloxazine in this patient population.

Related Experiment Videos